威耳宁改善慢性萎缩性胃炎伴肠上皮化生的实验研究
本研究探讨中成药威耳宁片(WEN)对慢性萎缩性胃炎(CAG)伴肠上皮化生的改善作用及机制。采用2%水杨酸钠和30%酒精复合造模溶液灌胃,结合不规则饮食和自由饮用0.1%氨水持续两个月建立大鼠CAG模型。结果显示WEN可剂量依赖性降低血清IL-1β及胃组织IL-6、IL-8、IL-10、TNF-α、γ-IFN的mRNA表达,减轻胃黏膜下胶原沉积,调节凋亡相关蛋白,并降低Cdx2、Muc2、Shh、Gli1、Smo蛋白表达,逆转肠上皮化生。
要点
- 威耳宁可剂量依赖性降低CAG大鼠血清IL-1β及胃组织炎症因子mRNA表达。
- 威耳宁通过调节Bax、Cleaved-caspase9、Bcl2、Cytochrome c减少胃黏膜上皮细胞凋亡。
- 威耳宁降低Cdx2、Muc2及Hedgehog通路蛋白表达,逆转肠上皮化生。
核心结论
- 威耳宁对慢性萎缩性胃炎有改善作用,并可逆转肠上皮化生。
- 上述作用与抑制胃黏膜细胞凋亡及抑制Hedgehog通路活化有关。
研究设计与样本
- 采用2%水杨酸钠和30%酒精复合造模溶液灌胃,结合不规则饮食和自由饮用0.1%氨水持续两个月建立大鼠CAG模型。
- 检测血清胃泌素、胃蛋白酶原及炎症因子水平,胃组织IL-6、IL-18、IL-10、TNF-α、γ-IFN的mRNA表达,胃黏膜病理及超微结构,肠上皮化生,线粒体凋亡相关蛋白和Hedgehog通路相关蛋白表达,以及Cdx2和Muc2蛋白表达。
主要发现
- 威耳宁可剂量依赖性降低血清IL-1β水平及胃组织IL-6、IL-8、IL-10、TNF-α、γ-IFN的mRNA表达。
- 威耳宁显著减轻胃黏膜下胶原沉积,调节Bax、Cleaved-caspase9、Bcl2和Cytochrome c表达以减少胃黏膜上皮细胞凋亡,维持胃黏膜屏障完整性。
- 威耳宁降低Cdx2、Muc2、Shh、Gli1和Smo蛋白表达,逆转胃黏膜肠上皮化生,阻断CAG进展。
临床怎么用
- 威耳宁作为临床用于慢性萎缩性胃炎的中成药,本实验提示其可能通过抗炎、抗凋亡及抑制Hedgehog通路改善CAG并逆转肠上皮化生。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Weierning tablet (WEN) is a traditional Chinese patent medicine widely used in clinical for chronic atrophic gastritis (CAG) therapy for years. However, the underlying mechanisms of WEN on anti-CAG are still unveiled. AIM OF THE STUDY: The present study aimed to elucidate the characteristic function of WEN on anti-CAG and to illuminate its potential mechanism. METHODS: The CAG model was established by gavage rats with a modeling solution (consisting of 2% sodium salicylate and 30% alcohol) with irregular diets and free access to 0.1% ammonia solution for two months on end. An enzyme-linked immunosorbent assay was used to measure the serum levels of gastrin, pepsinogen, and inflammatory cytokines. qRT-PCR was applied to measure mRNA expressions of IL-6, IL-18, IL-10, TNF-α, and γ-IFN in gastric tissue. Pathological changes and the ultrastructure of gastric mucosa were examined by hematoxylin and eosin staining and transmission electron microscopy, respectively. AB-PAS staining was applied to observe the intestinal metaplasia of gastric mucosa. Immunohistochemistry and Western blot were used to measure the expression levels of mitochondria apoptosis-related proteins and Hedgehog pathway-related proteins in gastric tissues. Expressions of Cdx2 and Muc2 protein were determined by immunofluorescent staining. RESULTS: WEN could dose-dependently lower the serum level of IL-1β and the mRNA expressions of IL-6, IL-8, IL-10, TNF-α, and γ-IFN in gastric tissue. Also, WEN significantly alleviated the collagen deposition in gastric submucosa, regulated the expressions of Bax, Cleaved-caspase9, Bcl2, and Cytochrome c to reduce the apoptosis of gastric mucosa epithelial cells, and maintained the integrity of the gastric mucosal barrier. Moreover, WEN could reduce protein expressions of Cdx2, Muc2, Shh, Gli1, and Smo, and reverse intestinal metaplasia of gastric mucosa to block the progress of CAG. CONCLUSION: This study demonstrated a positive effect of WEN on improving CAG and reverse intestinal metaplasia. These functions were related to the suppression of gastric mucosal cells' apoptosis and the inhibition of Hedgehog pathways' activation.
引用
- Han L, Li T, Wang Y, et al. Weierning, a Chinese patent medicine, improves chronic atrophic gastritis with intestinal metaplasia. J Ethnopharmacol. 2023. PMID: 36906155. doi:10.1016/j.jep.2023.116345
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。